Mindmed to host earnings call to discuss first quarter 2022 financial results and provide business update

New york , may 9, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on monday, may 16, 2022, at 8:30 a.m. edt to discuss its financial results for the quarter ended march 31, 2022 and provide a business update.
MNMD Ratings Summary
MNMD Quant Ranking